Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

KPTI Karyopharm Therapeutics Inc

1,08

-0,01 (-0,92%)

25 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Karyopharm Therapeutics (NASDAQ:KPTI)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Karyopharm Therapeutics Charts.

Karyopharm Therapeutics (NASDAQ:KPTI)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Karyopharm Therapeutics Charts.

News Karyopharm Therapeutics Inc

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Donnerstag 23 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
Mittwoch 8 Mai 2024 (3 Wochen vor) • PR Newswire (US)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
Mittwoch 8 Mai 2024 (3 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024
Donnerstag 2 Mai 2024 (3 Wochen vor) • PR Newswire (US)

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mittwoch 1 Mai 2024 (4 Wochen vor) • PR Newswire (US)

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
Mittwoch 24 April 2024 (1 Monat vor) • PR Newswire (US)

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Montag 1 April 2024 (2 Monate vor) • PR Newswire (US)

Weitere Karyopharm Therapeutics Inc News-Artikel

Societe Generale Societe...

Tagus SOC Titul Cred SA ...

Nh Qv Leverage Silver Fu...

Societe Generale SFH Dom...

Marti Technologies

Strategic Income Portfol...

Societe Generale SFH SA ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen